(Q28220366)

1

0 references

M Kyrgiou

2

0 references

T C Li

3

0 references

C Stern

4

0 references

L G Nardo

5

0 references

language of work or name

English

0 references

publication date

2007

1 reference

Human Reproduction Update

PubMed

published in

0 references

volume

13

0 references

issue

4

0 references

page(s)

357-64

0 references

cites work

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Antiphospholipid antibodies in women having in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Antiphospholipid antibodies associated with implantation failure after IVF/ET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Clinical management of low ovarian response to stimulation for IVF: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

Embryo quality and developmental potential is compromised by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM005

release_7ch6sovlpzfv3km54y5xbscctm

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMM005

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ch6sovlpzfv3km54y5xbscctm